166 related articles for article (PubMed ID: 11571630)
1. Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines.
Jasty R; van Golen C; Lin HJ; Solomon G; Heidelberger K; Polverini P; Opipari A; Feldman E; Castle VP
Neoplasia; 2001; 3(4):304-13. PubMed ID: 11571630
[TBL] [Abstract][Full Text] [Related]
2. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
3. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.
Noujaim D; van Golen CM; van Golen KL; Grauman A; Feldman EL
Oncogene; 2002 Jul; 21(29):4549-57. PubMed ID: 12085233
[TBL] [Abstract][Full Text] [Related]
4. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.
Ushmorov A; Hogarty MD; Liu X; Knauss H; Debatin KM; Beltinger C
Oncogene; 2008 May; 27(24):3424-34. PubMed ID: 18193081
[TBL] [Abstract][Full Text] [Related]
5. N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells.
van Golen CM; Soules ME; Grauman AR; Feldman EL
Oncogene; 2003 May; 22(17):2664-73. PubMed ID: 12730680
[TBL] [Abstract][Full Text] [Related]
6. Relationship between bcl-2 and myc gene expression in human neuroblastoma.
Ikegaki N; Katsumata M; Tsujimoto Y; Nakagawara A; Brodeur GM
Cancer Lett; 1995 May; 91(2):161-8. PubMed ID: 7767905
[TBL] [Abstract][Full Text] [Related]
7. IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma.
van Golen CM; Castle VP; Feldman EL
Cell Death Differ; 2000 Jul; 7(7):654-65. PubMed ID: 10889510
[TBL] [Abstract][Full Text] [Related]
8. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells.
Misawa A; Hosoi H; Arimoto A; Shikata T; Akioka S; Matsumura T; Houghton PJ; Sawada T
Cancer Res; 2000 Jan; 60(1):64-9. PubMed ID: 10646854
[TBL] [Abstract][Full Text] [Related]
9. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
10. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
Li J; Kretzner L
Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
[TBL] [Abstract][Full Text] [Related]
11. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation.
Screaton RA; Penn LZ; Stanners CP
J Cell Biol; 1997 May; 137(4):939-52. PubMed ID: 9151695
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes.
Valverde AM; Mur C; Brownlee M; Benito M
Mol Biol Cell; 2004 Nov; 15(11):5101-17. PubMed ID: 15356271
[TBL] [Abstract][Full Text] [Related]
14. N-myc modulates expression of p73 in neuroblastoma.
Zhu X; Wimmer K; Kuick R; Lamb BJ; Motyka S; Jasty R; Castle VP; Hanash SM
Neoplasia; 2002; 4(5):432-9. PubMed ID: 12192602
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164
[TBL] [Abstract][Full Text] [Related]
16. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification.
Roy Choudhury S; Karmakar S; Banik NL; Ray SK
Invest New Drugs; 2010 Dec; 28(6):812-24. PubMed ID: 19777160
[TBL] [Abstract][Full Text] [Related]
17. N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification.
Hossain MM; Banik NL; Ray SK
Gene; 2013 Oct; 529(1):27-36. PubMed ID: 23941992
[TBL] [Abstract][Full Text] [Related]
18. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
19. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
20. [Effects of antisense bcl-2 or survivin on the growth of human neuroblastoma cell line SK-N-MC].
Guan J; Chen J; Luo Y; Gao J; Qiu H
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1536-40. PubMed ID: 12609062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
